iSpecimen to Enact 1-for-40 Reverse Stock Split to Meet Nasdaq Listing Requirements
Summary
iSpecimen Inc. announced a 1-for-40 reverse stock split, effective April 27, 2026, with trading on a split-adjusted basis beginning April 28, 2026. This significant capital event is explicitly aimed at increasing the per-share trading price to comply with Nasdaq's minimum bid price requirement and maintain its listing. This action follows the company's recent 10-K filing, which reported a 79% revenue decline and expressed substantial doubt about its ability to continue as a going concern, alongside existing risks of significant shareholder dilution. While the reverse split addresses an immediate compliance issue, it does not resolve the fundamental operational and financial challenges facing the micro-cap company. Traders should monitor the stock's performance post-split and any further updates on the company's financial health and strategic initiatives.
At the time of this announcement, ISPC was trading at $0.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $0.10 to $3.18. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: TMX Newsfile.